郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders.

期刊：Current pharmaceutical design发表年份：2005作者：Guy Griebel; Jeanne Stemmelin; Claudine Serradeil-Le Gal; Philippe Soubrié
阅读更多 →

药效评价Atrial natriuretic peptide inhibits the actions of FSH and forskolin in meiotic maturation of pig oocytes via different signalling pathways.

期刊：Journal of molecular endocrinology发表年份：2005作者：M Zhang; Y Tao; B Zhou; H Xie; F Wang; L Lei; L Huo; Q Sun; G Xia
阅读更多 →

药效评价Cytoprotective effect of tectorigenin, a metabolite formed by transformation of tectoridin by intestinal microflora, on oxidative stress induced by hydrogen peroxide.

期刊：European journal of pharmacology发表年份：2005作者：Kyoung Ah Kang; Kyoung Hwa Lee; Sungwook Chae; Rui Zhang; Myung Sun Jung; So Young Kim; Hee Sun Kim; Dong Hyun Kim; Jin Won Hyun
阅读更多 →

药效评价Coelenterazine (marine bioluminescent substrate): a source of inspiration for the discovery of novel antioxidants.

期刊：Drug development and industrial pharmacy发表年份：2005作者：M L N Dubuisson; J-F Rees; J Marchand-Brynaert
阅读更多 →